Altria Group said Friday it agreed to buy a 45 percent stake in leading cannabinoid company Cronos Group for about $ 1.8 billion, a sign of the new world in which Altria must compete.
Health and Science
Altria to invest $1.8 billion in cannabis company Cronos Group, exits some e-cig brands